Organized by Joan Seoane, Director of Translational Research at VHIO, in collaboration with the European Association for Cancer Research (EACR), LIF as We Know It: From Basic Science to Clinical Trials, will be coming to VHIO’s CELLEX Auditorium, Barcelona, 28 – 29 May 2018, for a bench-bedside and back review of all the very latest insights in the field of LIF.
The superbly crafted scientific program features VHIO’s Director, Josep Tabernero, and José Baselga, Physician-in-Chief, Memorial Sloan Kettering Cancer Center, MSKCC (NYC, USA), and President of our Internal Scientific Committee, among many other internationally acclaimed trailblazers in oncology. Expertly engineered by Joan to offer speakers and participants alike a broad and comprehensive overview of the most recent developments in better understanding LIF biology, its implications in cancer and the development of anti-cancer agents, this two-day masterclass will center on topics ranging from embryonic stem cells, immunomodulation, therapeutic targets in cancer to drug design.
To view the program, apply for an EACR bursary before the deadline of 26 March, and register to attend by 30 April, click here.
